If its only treating mild comorbid weight, a planned taper after lifestyle change is reasonable
The article reports nausea in approximately 25 to 44 percent of patients on semaglutide at maintenance doses, and 25 to 33 percent for tirzepatide with vomiting in 1 to 6 percent, depending on dose and the population studied
The FDA issued guidance in 2023 stating BPC-157 cannot be compounded by 503A or 503B pharmacies in the United States because it is not on the approved bulk substances list
And it shows how broken this system has become
Based on similarities in their amino acid sequence, GLP-1RAs are peptide derivatives of either exendin-4 (exenatide, lixisenatide, and efpeglenatide) or human GLP-1 (albiglutide, dulaglutide, liraglutide, and semaglutide)